BACKGROUND: Permanent pacemaker implantation is accompanied by minor myocardial damage, indicated by elevated serum levels of cardiac biomarkers. Aim of this prospective study was to comparably investigate the lead fixation type effect on the extent of myocardial injury and inflammation following pacemaker implantation, and to assess the possible clinical implications. METHODS: Cardiac troponin I (cTnI) and C-reactive protein (CRP) were measured at baseline, 6 and 24h after implantation in 101 patients, categorized into the active and passive lead fixation group. Patients were followed up for clinical adverse events or abnormal pacing parameters at 24h, 7 and 30 days post-procedure. RESULTS: cTnI increased at 6h post-procedure (p<0.05) in 23.8% of patients, and returned to baseline after 24h. The passive group demonstrated significantly higher cTnI at 6h compared to the active group (p=0.006). CRP increased significantly at 6h, and maintained an upward trend after 24h (p<0.01) in both groups. The active group demonstrated significantly higher CRP at 6h compared to the passive group. We did not identify an association of positive biomarkers with adverse events. CONCLUSION: cTnI and CRP can increase early after permanent pacemaker implantation, indicating mechanical myocardial injury and inflammation. The extent of these biomarkers elevation depends on the lead fixation type, and is not related to worse short-term prognosis.
BACKGROUND: Permanent pacemaker implantation is accompanied by minor myocardial damage, indicated by elevated serum levels of cardiac biomarkers. Aim of this prospective study was to comparably investigate the lead fixation type effect on the extent of myocardial injury and inflammation following pacemaker implantation, and to assess the possible clinical implications. METHODS: Cardiac troponin I (cTnI) and C-reactive protein (CRP) were measured at baseline, 6 and 24h after implantation in 101 patients, categorized into the active and passive lead fixation group. Patients were followed up for clinical adverse events or abnormal pacing parameters at 24h, 7 and 30 days post-procedure. RESULTS: cTnI increased at 6h post-procedure (p<0.05) in 23.8% of patients, and returned to baseline after 24h. The passive group demonstrated significantly higher cTnI at 6h compared to the active group (p=0.006). CRP increased significantly at 6h, and maintained an upward trend after 24h (p<0.01) in both groups. The active group demonstrated significantly higher CRP at 6h compared to the passive group. We did not identify an association of positive biomarkers with adverse events. CONCLUSION: cTnI and CRP can increase early after permanent pacemaker implantation, indicating mechanical myocardial injury and inflammation. The extent of these biomarkers elevation depends on the lead fixation type, and is not related to worse short-term prognosis.
Entities:
Keywords:
C-reactive protein; Lead fixation; Pacemaker; Troponin
Authors: Nikolaos I Nikolaou; Apostolos H Christou; Stavros G Spanodimos; Dionysios G Antonatos; Panagiotis I Korkonikitas; Sotirios P Patsilinakos Journal: Hellenic J Cardiol Date: 2011 Nov-Dec
Authors: Harry G Mond; John R Helland; Kenneth Stokes; Gene A Bornzin; Rick McVenes Journal: Pacing Clin Electrophysiol Date: 2014-07-29 Impact factor: 1.976
Authors: Nikolaos I Nikolaou; Stavros G Spanodimos; Elias P Tsaglis; Dionysios G Antonatos; Sotiris P Patsilinakos; Georgios M Fournarakis; Dimitrios L Tsigas Journal: Pacing Clin Electrophysiol Date: 2005-11 Impact factor: 1.976
Authors: Tomas Hnatek; Milos Taborsky; Martin Maly; Libor Kamenik; Simona Littnerova; Pavel Sedlon; Jana Luxova; Marta Fiserova; Lenka Pospisilova; Sarka Hamouzova; Josef Danek; Miroslav Zavoral Journal: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Date: 2016-01-13 Impact factor: 1.245